Facebook
Twitter
LinkedIn
Forward
Tenth Annual Advances in Hematology and Oncology Fall Virtual Symposium
THIS SYMPOSIUM HAS BEEN CHANGED TO A VIRTUAL EVENT!
The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The 10th Annual Advances in Hematology and Oncology Fall Symposium will update participants on symptom management, prostate cancer, transplantation and cellular therapies for multiple myeloma, immune therapy for lung cancer, fertility preservation and more.
The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses
Learning Objectives
- Attendees will be able to identify current evidence-based practice guidelines for topics presented.
- Attendees will be able to identify current available clinical trials for potential enrollment to benefit their patients.
- Discuss the most current scientific and clinical research data and apply information to clinical practice.
AGENDA
7:00-7:55AM Viewing Exhibits
7:55-8:00AM Introduction | John Burfeind, MD
8:00-8:45 AM Selecting, Administering and Monitoring Immunotherapy for Lung Cancer | David Gerber, MD
8:45-9:30AM Autologous Stem Cell Transplantation and Cellular Therapies for Multiple Myeloma | Meera Mohan, MD, MS
9:30-10:15AM PSMA Targeted Therapy: Promising New Treatments for Men in Advanced Prostate Cancer | Kathryn Bylow, MD
10:15-10:30AM Break/View Exhibits
10:30-11:15AM Breakout Sessions:
- Implementing Scalp Cooling for Chemotherapy Induced Alopecia at a Community-Based Cancer Center | Linda Amacher, RN, BSN, OCN, Denise Herriges, RN, BSN, OCN, and Denise Portz, MSN, RN, ACNS-BC, AOCNS
- Controversies in Cancer Associated Venous Thrombosis | Patrick Foy, MD
11:15-12:00PM Fertility Preservation: The Future is Bright | Stephanie Gunderson, MD
12:00 Adjournment
Guest Speakers
David E. Gerber, MD
Professor of Internal Medicine and Population Data Sciences
Associate Director of Clinical Research
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
Linda Amacher, RN, BSN, OCN
Infusion Staff RN
Division of Hematology & Oncology
Froedtert & the Medical College of Wisconsin
Kathryn Bylow, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Patrick C. Foy, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Stephanie Gunderson, MD
Assistant Professor
Department of Obstetrics & Gynecology
Medical College of Wisconsin
Denise Herriges, RN, BSN, OCN
Infusion Staff RN
Division of Hematology and Oncology
Froedtert & the Medical College of Wisconsin
Meera Mohan, MD, MS
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Denise Portz, MSN, RN, ACNS-BC, AOCNS
Oncology Clinical Nurse Specialist
Division of Hematology and Oncology
Froedtert & the Medical College of Wisconsin
Planning Committee
John Burfeind, MD, Program Co-Director
Amy Harker-Murray, MD, Program Co-Director
Dan Bullock
All persons in control of content have NO relevant relationships to disclose with the exception of:
| Name | Company | Relationship |
|---|---|---|
| David E. Gerber, MD | AstraZeneca, Karyopharm, BerGenBio Gilead Samsung Bioepis, Catalyst Pharmaceuticals, BMS Steering Committee, Bei Gene, Ltd., Mriati Therapeutics, Inc., Janssen Scientific | Research Investor Consulting |
|
|
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.
Available Credit
- 3.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.75 Hours of ParticipationHours of Participation credit.